Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Aug;9(4):493-496.
doi: 10.21037/hbsn.2019.11.11.

Nonalcoholic fatty liver disease in type 2 diabetes: awareness is the first step toward change

Fernando Bril  1   2
Affiliations
Editorial

Nonalcoholic fatty liver disease in type 2 diabetes: awareness is the first step toward change

Fernando Bril. Hepatobiliary Surg Nutr. 2020 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/hbsn.2019.11.11). The author has no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Summary of the prevalence of liver disease among patients with type 2 diabetes mellitus (T2DM) and the overall population based on studies by Younossi et al. (1,5).
Figure 2
Figure 2
Prediction of progression of liver disease and mortality after 10 years of follow-up in patients with type 2 diabetes mellitus (T2DM) and the overall population based on results from prior studies (1,5).
See this image and copyright information in PMC

Comment on

References

    1. Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. J Hepatol 2019;71:793-801. 10.1016/j.jhep.2019.06.021 - DOI - PubMed
    1. Bril F, Portillo-Sanchez P, Liu IC, et al. Clinical and histologic characterization of nonalcoholic steatohepatitis in African American patients. Diabetes Care 2018;41:187-92. 10.2337/dc17-1349 - DOI - PubMed
    1. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387-95. 10.1002/hep.20466 - DOI - PubMed
    1. Setiawan VW, Stram DO, Porcel J, et al. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort. Hepatology 2016;64:1969-77. 10.1002/hep.28677 - DOI - PMC - PubMed
    1. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84. 10.1002/hep.28431 - DOI - PubMed